Uniqure NV Correlations

QURE Stock

USD 14.04 0.73 5.48%

The current 90-days correlation between Uniqure NV and Rocket Pharmaceuticals is 0.5 (i.e., Very weak diversification). The correlation of Uniqure NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Uniqure NV Correlation With Market

Weak diversification

The correlation between Uniqure NV and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Uniqure NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.

Moving together with Uniqure Stock

0.72	ME	23Andme Holding	Pair Corr
0.63	VANI	Vivani Medical Earnings Call This Week	Pair Corr
0.61	VCYT	Veracyte	Pair Corr
0.83	VERA	Vera Therapeutics	Pair Corr
0.67	DSGN	Design Therapeutics Potential Growth	Pair Corr
0.74	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.75	VKTX	Viking Therapeutics	Pair Corr
0.67	DYAI	Dyadic International Earnings Call This Week	Pair Corr
0.9	VRDN	Viridian Therapeutics	Pair Corr
0.72	VRPX	Virpax Pharmaceuticals	Pair Corr
0.7	VTRS	Viatris	Pair Corr
0.81	VTYX	Ventyx Biosciences	Pair Corr

Moving against Uniqure Stock

0.73	VALN	Valneva SE ADR	Pair Corr
0.58	VIGL	Vigil Neuroscience	Pair Corr
0.57	DTIL	Precision BioSciences Earnings Call This Week	Pair Corr
0.55	DVAX	Dynavax Technologies	Pair Corr
0.41	DMAC	DiaMedica Therapeutics	Pair Corr
0.4	EQ	Equillium	Pair Corr
0.71	VRNA	Verona Pharma PLC	Pair Corr
0.63	VRTX	Vertex Pharmaceuticals	Pair Corr
0.53	VTVT	vTv Therapeutics	Pair Corr
0.53	EDSA	Edesa Biotech	Pair Corr
0.43	EDIT	Editas Medicine	Pair Corr
0.35	VSTM	Verastem	Pair Corr

Related Correlations Analysis

	RCKT	RYTM	SLDB	MGTX	TERN	AMLX	ABOS	INZY	XFOR	PCVX
RCKT		0.66	-0.31	-0.51	0.91	0.64	0.92	0.86	0.89	0.71	RCKT
RYTM	0.66		-0.57	-0.24	0.46	0.25	0.47	0.34	0.67	0.76	RYTM
SLDB	-0.31	-0.57		0.48	-0.26	-0.02	-0.33	-0.12	-0.39	-0.65	SLDB
MGTX	-0.51	-0.24	0.48		-0.56	-0.27	-0.58	-0.48	-0.5	-0.42	MGTX
TERN	0.91	0.46	-0.26	-0.56		0.76	0.95	0.94	0.82	0.65	TERN
AMLX	0.64	0.25	-0.02	-0.27	0.76		0.71	0.75	0.56	0.4	AMLX
ABOS	0.92	0.47	-0.33	-0.58	0.95	0.71		0.87	0.81	0.71	ABOS
INZY	0.86	0.34	-0.12	-0.48	0.94	0.75	0.87		0.81	0.45	INZY
XFOR	0.89	0.67	-0.39	-0.5	0.82	0.56	0.81	0.81		0.66	XFOR
PCVX	0.71	0.76	-0.65	-0.42	0.65	0.4	0.71	0.45	0.66		PCVX
	RCKT	RYTM	SLDB	MGTX	TERN	AMLX	ABOS	INZY	XFOR	PCVX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ABOS	+ 0.95	TERN
INZY	+ 0.94	TERN
ABOS	+ 0.92	RCKT
TERN	+ 0.91	RCKT
XFOR	+ 0.89	RCKT
INZY	+ 0.87	ABOS

High negative correlations

PCVX	- 0.65	SLDB
ABOS	- 0.58	MGTX
SLDB	- 0.57	RYTM
TERN	- 0.56	MGTX
MGTX	- 0.51	RCKT
XFOR	- 0.5	MGTX

Risk-Adjusted Indicators

There is a big difference between Uniqure Stock performing well and Uniqure NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Uniqure NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RCKT	2.76	(0.56)	0.00	(0.56)	0.00	0.00	4.92	(6.06)	12.71
RYTM	1.86	(0.07)	0.00	(0.23)	0.00	0.00	3.60	(4.39)	13.95
SLDB	5.14	0.41	0.06	0.09	5.08	(6.74)	11.61	(8.68)	41.64
MGTX	3.12	0.34	0.12	(1.02)	3.44	(3.49)	5.56	(5.58)	34.28
TERN	3.01	(1.03)	0.00	(1.35)	0.00	0.00	4.94	(6.98)	19.13
AMLX	3.74	(0.09)	0.00	(0.16)	0.00	0.00	7.20	(9.09)	21.45
ABOS	2.93	(0.64)	0.00	(0.62)	0.00	0.00	6.57	(5.85)	19.77
INZY	3.98	(1.35)	0.00	(0.93)	0.00	0.00	6.82	(9.17)	36.29
XFOR	6.95	(0.70)	0.00	(2.58)	0.00	0.00	13.43	(14.29)	68.45
PCVX	2.23	(0.14)	0.00	(0.21)	0.00	0.00	3.86	(4.85)	19.90

Uniqure NV Corporate Management

Maria Cantor	Chief Officer	Profile
Carla Poulson	Interim Officer	Profile
Alexander Kuta	Ex Affairs	Profile
Ricardo Dolmetsch	Pres RD	Profile
Pierre Caloz	Chief Officer	Profile
Eileen Sawyer	Vice Affairs	Profile
Amin Abujoub	Chief Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC